Biểu đồ giá cổ phiếu TTRX
TTRX Dự đoán giá cổ phiếu
Turn Therapeutics Inc
$7.12
3.94%
$0.27
Khi đóng cửa: Jul 02, 16:00:00 GMT-4
$7.12
0%
$0
Phiên sau giờ: Jul 02, 20:00:00 GMT-4
Quay lại
Turn Therapeutics Inc (TTRX) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$6.85
Giá mở cửa
$6.94
Phạm vi ngày
$6.83 - $7.32
Phạm vi 52 tuần
$2.57 - $26.5
Khối lượng
20.5K
Khối lượng trung bình
32.6K
Tỷ suất cổ tức
--
EPS (TTM)
-0.13
Vốn hóa thị trường
$212.1M
TTRX là gì?
Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. The company is headquartered in Westlake Village, California. The company went IPO on 2025-10-08. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.
